| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6182889 | Gynecologic Oncology | 2012 | 5 Pages |
Abstract
⺠An intensive CA125 monitoring schedule demonstrates a similar rate of CA125 normalization with IP versus IV treatment. ⺠Prognostic data to stratify subgroups most appropriate for novel consolidation or maintenance treatment strategies are identified.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Ginger J. Gardner, Raymond E. Baser, Mark F. Brady, Robert E. Bristow, Maurie Markman, David Spriggs, Howard T. Thaler,